Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Telemedycyna PolskaWAR:TMP +1.56%28 PB Ratio is 72.22 as of Aug. 02, 2026, which is 930% above its 10-year median of 7.01. GuruFocus rates WAR:TMP with a GF Score™ of 28/100 and a GF Value™ of zł0.82 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 608 Healthcare Providers & Services companies, Telemedycyna Polska ranks worse than 99.67% on this metric.
The historical rank and industry rank for Telemedycyna Polska's PB Ratio or its related term are showing as below:
WAR:TMP'
s PB Ratio Range Over the Past 10 Years
Min: 2.62 Med: 7.01 Max: 83.33
Current: 72.22
During the past 13 years, Telemedycyna Polska's highest PB Ratio was 83.33. The lowest was 2.62. And the median was 7.01.
WAR:TMP's PB Ratio is ranked worse than 99.67% of 608
companies
in the Healthcare Providers & Services industry
Industry Median: 2.05
vs WAR:TMP: 72.22
During the past 12 months, Telemedycyna Polska's average Book Value Per Share Growth Rate was -85.20% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -62.30% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -45.70% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was -13.80% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Telemedycyna Polska was 57.80% per year. The lowest was -62.30% per year. And the median was -8.20% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Telemedycyna Polska PB Ratio Related Terms
Telemedycyna Polska PB Ratio Historical Data
* Premium members only.
The historical data trend for Telemedycyna Polska's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Telemedycyna Polska's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Telemedycyna Polska PB Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Telemedycyna Polska's PB Ratio distribution charts can be found below:
* The bar in red indicates where Telemedycyna Polska's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Telemedycyna Polska (WAR:TMP) has a PB Ratio of 72.22 as of Aug. 02, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Telemedycyna Polska and its competitors. This is 930% above median its historical median of 7.01. Over the past decade, Telemedycyna Polska's PB Ratio has ranged from 2.62 to 83.33. According to the industry distribution chart, Telemedycyna Polska ranks #606 out of 608 companies in the Healthcare Providers & Services industry, placing it in the top 99.7%.
Is Telemedycyna Polska's PB Ratio too high?
Telemedycyna Polska's current PB Ratio of 72.22 is 930% above median its 10-year median of 7.01. Over the past 10 years, this metric has ranged from a low of 2.62 to a high of 83.33. The Healthcare Providers & Services industry median PB Ratio is 2.05. Telemedycyna Polska's value of 72.22 is 3422.9% above this industry median. Based on the distribution chart, Telemedycyna Polska ranks #606 out of 608 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Telemedycyna Polska has a GF Score™ of 28/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Telemedycyna Polska's PB Ratio compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Telemedycyna Polska ranks #606 out of 608 companies for PB Ratio. This places Telemedycyna Polska in the lower half of its industry. The industry median PB Ratio is 2.05. Telemedycyna Polska's value of 72.22 is 3422.9% above this benchmark. Historically, Telemedycyna Polska's own PB Ratio has ranged from 2.62 to 83.33 over the past decade. While the company's 10-year median is 7.01 vs. the industry median of 2.05, Telemedycyna Polska has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Healthcare Providers & Services company?
The median PB Ratio among Healthcare Providers & Services companies is 2.05, based on 608 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Telemedycyna Polska's current PB Ratio of 72.22 is 3422.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Telemedycyna Polska and its competitors. For the Healthcare Providers & Services industry, the median PB Ratio is 2.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Telemedycyna Polska's current PB Ratio is 72.22, which is 930% above median its own 10-year median of 7.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Telemedycyna Polska stock overvalued right now?
Based on GuruFocus' analysis, Telemedycyna Polska (WAR:TMP) is currently considered Modestly Undervalued. The stock's GF Value™ is zł0.82, compared to a current price of zł0.65 — trading 20.7% below its estimated fair value. The current PB Ratio is 72.22, which is 930% above median its 10-year median of 7.01 and 3422.9% above the Healthcare Providers & Services industry median of 2.05. Telemedycyna Polska's overall GF Score™ is 28/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Telemedycyna Polska (WAR:TMP), the current PB Ratio is 72.22 as of Aug. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Telemedycyna Polska (WAR:TMP) Overvalued in 2026?
Based on GuruFocus' analysis, Telemedycyna Polska stock appears to be undervalued.
The current stock price of zł0.65 is trading 20.7% below its estimated GF Value™ of zł0.82.
GuruFocus considers Telemedycyna Polska to be Modestly Undervalued.
Key valuation signals for WAR:TMP:
PB Ratio: 72.22 (930% above median its 10-year median of 7.01)
GF Value™: zł0.82 vs. price of zł0.65 (20.7% below fair value)
Industry Position: 3422.9% above the Healthcare Providers & Services median (#606 of 608)
No single metric tells the full story. See the WAR:TMP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Telemedycyna Polska SA offers telecardiology services for individual patients and medical facilities in Poland. The company offers cardiologic care services through telephone and Internet. The company also provides telemedical services to health centres.
28GF Score
Get the complete analysis for WAR:TMP
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:TMP has been successfully added to your 
